| Literature DB >> 35509003 |
Ya Liang1, Qiuli Yu2, Hong Sun1, Liuwei Gu1, Zhilan Yuan3.
Abstract
BACKGROUND: To evaluate the efficacy and safety of modified suture-assisted canaloplasty in Asians with primary open-angle glaucoma (POAG).Entities:
Keywords: Canaloplasty; Primary open-angle glaucoma; Schlemm’s canal; Suture; Viscocanalostomy
Mesh:
Year: 2022 PMID: 35509003 PMCID: PMC9066751 DOI: 10.1186/s12886-022-02424-9
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.086
Fig. 1Characterization of cannulation materials. a 5/0 polypropylene suture with a mushroom-shaped tip. b Twisted 6/0 polypropylene suture with a loop tip. c iTrack™ with an inflated tip. d 5/0 polypropylene suture with a rough and sharp margin. e Twisted 6/0 polypropylene suture with a smooth tip. f The measurement of contact angle. A 5 µl droplet (red arrow) of distilled water from a very thin tube (yellow arrow) was used for contact angle measurement of polypropylene sutures (blue arrow). The angle (red angle) between the droplet (red arrow) and the surface of the suture (blue arrow) was 150°, which indicated the polypropylene was hydrophobic and stable in water. g Fourier transform infrared (FTIR) spectra of the polypropylene suture and iTrack™
Fig. 2Surgical procedure. a A superficial and parabolic scleral flap was made, and a deep scleral flap of 3 × 3 mm was dissected, opening Schlemm’s canal(SC). b A twisted 6/0 polypropylene suture was prepared. c The loop tip was inserted into one ostium of SC. d The tip came out from the other ostium through 360-degree advancement. The loop tip was then wrapped with the 10/0 suture. e The 6/0 suture was withdrawn and replaced by a twin 10/0 suture in SC. f The 10/0 suture was tied with a tension distending the trabecular meshwork
Fig. 3Postoperative view of gonioscopy. Red arrows indicate the 10/0 suture. a Superior quadrant. b Nasal quadrant. c Inferior quadrant. d Temporal quadrant
Comparison of physical parameters of probing materials
| Parameters | 5/0 suture | Twisted 6/0 suture | iTrack™ |
|---|---|---|---|
| Maximum diameter of the tip (μm) | 390 | 290 | 250 |
| Maximum diameter of the body (μm) | 150 | 200 | 200 |
| Water contact angle (°) | 150 | 150 | N/A |
N/A not applicable
Demographic and baseline data
| Characteristics | Total | Successful catheterization | Failed catheterization |
|---|---|---|---|
| No. of patients | 40 | 36 | 4 |
| No. of eyes | 40 | 36(90%) | 4(10%) |
| Gender | |||
| Male/Female | 36/4 | 33/3 | 3/1 |
| Side | |||
| Right/Left | 20/20 | 20/16 | 0/4 |
| Age at surgery (year) | |||
| Mean ± SD | 47.4 ± 9.9(34–70) | 47.6 ± 10.3(34–70) | 45.3 ± 6.0(40–53) |
| Follow-up time (month) | |||
| Mean ± SD | 15.0 ± 3.0 (12–18) | 14.8 ± 3.0 (12–18) | 16.5 ± 3.0 (12–18) |
| C/D | |||
| Mean ± SD | 0.86 ± 0.13 (0.6–1.0) | 0.86 ± 0.13 (0.6–1.0) | 0.88 ± 0.19 (0.6–1.0) |
| BCVA (LogMAR) | |||
| Mean ± SD | 0.62 ± 0.74 (-0.08 ~ 2.6) | 0.61 ± 0.72 (-0.08 ~ 2.6) | 0.74 ± 1.07 (-0.08–2.3) |
| SE (D) | |||
| Mean ± SD | -4.35 ± -5.00 (0 ~ -18) | -4.56 ± -5.17 (0 ~ -18) | -2.50 ± -2.89 (0 ~ -5) |
| MD (dB) | |||
| Mean ± SD | -15.75 ± 7.40 (-29.13 ~ -1.21) | -16.50 ± 6.99 (-29.13 ~ -2.42) | -7.27 ± 7.94 (-16.25 ~ -1.21) |
| Preoperative IOP (mmHg) | |||
| Mean ± SD | 26.8 ± 7.6 (22–50) | 26.2 ± 6.9 (22–48) | 32.0 ± 12.8 (22–50) |
| No. of preoperative medications | |||
| Mean ± SD | 3.2 ± 0.6(2–4) | 3.2 ± 0.6(2–4) | 3.0 ± 0.0(3–3) |
NO number, C/D cup-to-disc ratio, BCVA best-corrected visual acuity, LogMAR log of the minimum angle of resolution, SE spherical equivalent, IOP intraocular pressure
Preoperative and postoperative IOP and anti-glaucoma agents
| Time | IOP (mmHg) Mean ± SD (range) | IOP reduction | Number of agents Mean ± SD (range) | n |
|---|---|---|---|---|
| Preoperative | 26.2 ± 6.9 (22–48) | 3.2 ± 0.6 (2–4) | 36 | |
| 1 day | 11.8 ± 4.3 (6–21) | 55.0% | 0 | 36 |
| 1 week | 13.9 ± 5.0 (7–35) | 46.9% | 0 | 36 |
| 1 month | 14.9 ± 4.5 (8–35) | 43.1% | 0.6 ± 0.9 (0–3) | 36 |
| 3 months | 14.5 ± 4.3 (8–35) | 44.7% | 0.6 ± 0.9 (0–3) | 36 |
| 6 months | 14.2 ± 2.9 (9–21) | 45.8% | 0.5 ± 0.8 (0–2) | 35 |
| 9 months | 14.3 ± 2.7 (9–20) | 45.4% | 0.5 ± 0.8 (0–2) | 35 |
| 12 months | 14.5 ± 2.7 (9–20) | 44.7% | 0.5 ± 0.8 (0–2) | 35 |
| 18 months | 15.1 ± 2.5 (10–18) | 42.4% | 0.8 ± 0.9 (0–2) | 17 |
| < 0.001* | < 0.001* |
IOP intraocular pressure, SD standard deviation, 1 mmHg = 0.133 kPa, n sample size
*Repeated measured ANOVA
Fig. 4Intraocular pressure (IOP) before and after modified suture-assisted canaloplasty (**p < 0.001)
Fig. 5Kaplan–Meier survival plot of cumulative probability of qualified success with intraocular pressure (IOP) ≤ 21, 18 and 15 mmHg and ≥ 20% IOP reduction
Complications during and after the surgery
| Complications | n(%) |
|---|---|
| Hyphema | 11(30.6) |
| IOP spike | 3(8.3) |
| Peripheral anterior synechia to the TDM | 1(2.7) |
IOP intraocular pressure, TDM trabecular-Descemet’s membrane